User profiles for "author:Hans Vasen"
Hans FA VasenProfessor Hereditary Cancer, Leiden University Medical Center, Leiden, The Netherlands Verified email at stoet.nl Cited by 60639 |
Peutz–Jeghers syndrome: a systematic review and recommendations for management
Peutz–Jeghers syndrome (PJS, MIM175200) is an autosomal dominant condition defined by
the development of characteristic polyps throughout the gastrointestinal tract and …
the development of characteristic polyps throughout the gastrointestinal tract and …
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
HFA Vasen, G Möslein, A Alonso, I Bernstein… - Journal of medical …, 2007 - jmg.bmj.com
Lynch syndrome (hereditary non-polyposis colorectal cancer) is characterised by the
development of colorectal cancer, endometrial cancer and various other cancers, and is …
development of colorectal cancer, endometrial cancer and various other cancers, and is …
Mutations associated with HNPCC predisposition--Update of ICG-HNPCC/INSiGHT mutation database
P Peltomäki, H Vasen - Disease markers, 2004 - content.iospress.com
Abstract In 1994, the International Collaborative Group on Hereditary Nonpolyposis
Colorectal Cancer (ICG-HNPCC) established an international database of mutations …
Colorectal Cancer (ICG-HNPCC) established an international database of mutations …
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
Hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome, is a
common autosomal dominant syndrome characterized by early age at onset, neoplastic …
common autosomal dominant syndrome characterized by early age at onset, neoplastic …
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC
HFA Vasen, P Watson, JP Mecklin, HT Lynch - Gastroenterology, 1999 - Elsevier
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome)
proposed by the International Collaborative Group on HNPCC - ScienceDirect Skip to main …
proposed by the International Collaborative Group on HNPCC - ScienceDirect Skip to main …
The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC)
HFA Vasen, JP Mecklin, PM Khan… - Diseases of the Colon & …, 1991 - journals.lww.com
H ereditary non-polyposis colorectal cancer (HNPCC) accounts for 5-10 percent of all the
cases of colorectal adenocarcinoma. Because of the paucity of carefully investigated and …
cases of colorectal adenocarcinoma. Because of the paucity of carefully investigated and …
[HTML][HTML] Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
Background Observational studies report reduced colorectal cancer in regular aspirin
consumers. Randomised controlled trials have shown reduced risk of adenomas but none …
consumers. Randomised controlled trials have shown reduced risk of adenomas but none …
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis
BACKGROUND & AIMS: Hereditary nonpolyposis colorectal cancer is characterized by early-
onset colorectal cancer and the occurrence of various other cancers. The recent isolation of …
onset colorectal cancer and the occurrence of various other cancers. The recent isolation of …
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Lynch syndrome (LS) is characterised by the development of colorectal cancer, endometrial
cancer and various other cancers, and is caused by a mutation in one of the mismatch repair …
cancer and various other cancers, and is caused by a mutation in one of the mismatch repair …
Guidelines for the clinical management of familial adenomatous polyposis (FAP)
HFA Vasen, G Moeslein, A Alonso, S Aretz, I Bernstein… - Gut, 2008 - gut.bmj.com
Background: Familial adenomatous polyposis (FAP) is a well-described inherited syndrome,
which is responsible for< 1% of all colorectal cancer (CRC) cases. The syndrome is …
which is responsible for< 1% of all colorectal cancer (CRC) cases. The syndrome is …